The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relation between dexamethasone (DEX) usage, preventive trimetprim/sulfametoxazole (ST), and pneumocystis pneumonia (PCP) for patients with breast cancer receiving dose-dense AC followed by dose-dense paclitaxel (ddAC-ddP): Preplanned analysis of WJOG9016B.
 
Koji Matsumoto
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Kyowa Hakko Kirin; Nihonkayaku; Novartis; Ono Pharmaceutical
Research Funding - AstraZeneca; MSD; Novartis; Ono Pharmaceutical
 
Meiko Nishimura
No Relationships to Disclose
 
Yukinori Ozaki
No Relationships to Disclose
 
Manabu Futamura
No Relationships to Disclose
 
Toshikio Miyaki
No Relationships to Disclose
 
Junji Tsurutani
Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Asahi Kasei; Daiichi Sankyo; Daiwa Securities
Speakers' Bureau - Daiichi Sankyo
Research Funding - Boehringer Ingelheim
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Shigeru Imoto
Honoraria - AstraZeneca Japan
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Mihoko Doi
No Relationships to Disclose
 
Shinya Tokunaga
No Relationships to Disclose
 
Kenjiro Aogi
Honoraria - AstraZeneca Japan; Chugai Pharma; Daiichi Sankyo; Eisai; Lilly; Mochida Pharmaceutical Co. Ltd.; Novartis; Ono Pharmaceutical; Otsuka; Sanofi; SRL Diagnostics; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Eisai (Inst); Sanofi (Inst)
 
Kenichi Yoshimura
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Eisai; Lilly; Taiho Pharmaceutical; Takeda
 
Hideaki Okada
No Relationships to Disclose
 
Yasuaki Sagara
No Relationships to Disclose
 
Motoi Baba
No Relationships to Disclose
 
Shigenori E. Nagai
No Relationships to Disclose
 
Toshimi Takano
Honoraria - Daiichi Sankyo; Eisai; Kyowa Hakko Kirin
Research Funding - Chugai Pharma (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)